Hyperthyroidism is a condition in which the thyroid gland produces an excess of thyroid hormones—thyroxine (T4) and triiodothyronine (T3)—which accelerate all metabolic processes. The diagnosis is based on a blood test measuring TSH; a low TSH level combined with elevated T3 and T4 levels confirms overproduction. A thyroid ultrasound and a thyroid scan are used to complete the evaluation and identify the cause.
Graves’ disease, an autoimmune disorder, is the most common cause: antibodies continuously stimulate the thyroid, bypassing normal regulatory mechanisms. Autonomous secretory nodules and thyroiditis can also cause excessive hormone production. Excessive iodine intake—through certain medications such as amiodarone or concentrated supplements—is also among the identified triggers.
The accelerated metabolism produces a characteristic clinical picture: weight loss despite an increased appetite, rapid heart rate, nervousness, tremors, and insomnia. Excessive sensitivity to heat, changes in the menstrual cycle, and paradoxical fatigue are frequently present as well. The severity of symptoms varies depending on the degree of hormonal overproduction and the duration of the untreated condition.
There are three treatment options. Antithyroid medications —methimazole or propylthiouracil—block hormone synthesis and are often the first-line treatment. Radioactive iodine therapy gradually destroys the overactive thyroid tissue. Surgery, either partial or total, is reserved for large goiters, suspicious nodules, or when other approaches are contraindicated. The choice depends on the cause, the patient’s age, and their overall medical condition.
Untreated hyperthyroidism can lead to serious complications. Thyrotoxic crisis —acute decompensation—is a life-threatening emergency. In the longer term, excess hormone production weakens the bones and promotes the loss of bone calcium. Cardiovascular risk also increases, with a higher likelihood of atrial fibrillation and heart failure. Early treatment remains essential.
Yes, particularly in Graves’ disease, where relapses after discontinuing antithyroid medications are common. Regular medical follow-up —including TSH and stimulating antibody testing—allows for the detection of any relapse and adjustment of the treatment strategy. Some patients require radical treatment with radioactive iodine or surgery to achieve lasting remission.
Yes. Poorly controlled hyperthyroidism during pregnancy increases the risk of miscarriage, preterm birth, preeclampsia, and fetal growth restriction. Treatment must be adjusted to minimize effects on the baby’s development, prioritizing medications with the lowest placental transfer. Close obstetric monitoring is essential throughout pregnancy.
Stress does not cause hyperthyroidism, but it can worsen symptoms in susceptible individuals by exacerbating nervousness, palpitations, and insomnia. Relaxation techniques—meditation, yoga, and cardiac coherence—help modulate the stress response and alleviate symptoms, though they are not a substitute for medical treatment.
Certain dietary adjustments can support management. Limiting foods very high in iodine reduces thyroid stimulation. Selenium plays a modulatory role in thyroid autoimmunity and may be considered under medical supervision. Adequate calcium intake helps preserve bone density compromised by hormonal excess. These complementary approaches must always be part of specialized medical care.
